Middle East tender deferral persists
Tender-based supplies to the Middle East remain on hold due to geopolitical tensions, with no clear timeline for resumption.
CONCORDBIO / Q3-FY26 / risks
Keep the risk register visible.
Concord Biotech · Material risks, their source context, and severity in the latest available quarter.
Research layer active
ConCallIQ research layer
Signal, with the source still visible.
Use the controls below to narrow the view, then follow the evidence into the next layer of context.
Risk intelligence
Material risks this quarter
medium
Injectable ramp-up slower than expected
The injectable facility is still in early stages; revenue contribution was insignificant in Q3, and scaling up may take longer than anticipated.
US tariff uncertainty for new products
While tariffs do not apply to already-launched generics, new product launches could be impacted if tariff policies change, as noted in analyst Q&A.